Amelie Schreieck
Senior Manager - Biomarker Development Immunic Therapeutics
Seminars
Wednesday 2nd December 2026
Building the Translational Evidence for Nurr1 Activation in Multiple Sclerosis from Preclinical Discovery to Clinical Biomarkers
3:30 pm
